Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Hybrid TSR⁻PSR Alternate Energy Harvesting Relay Network over Rician Fading Channels: Outage Probability and SER Analysis.

Nguyen TN, Tran Tin P, Ha DH, Voznak M, Tran PT, Tran M, Nguyen TL.

Sensors (Basel). 2018 Nov 9;18(11). pii: E3839. doi: 10.3390/s18113839.

2.

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.

Isaacsson Velho P, Qazi F, Hassan S, Carducci MA, Denmeade SR, Markowski MC, Thorek DL, DeWeese TL, Song DY, Tran PT, Eisenberger MA, Antonarakis ES.

Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30729-2. doi: 10.1016/j.eururo.2018.09.040. [Epub ahead of print]

PMID:
30293905
3.

Liquid lipase-catalyzed hydrolysis of gac oil for fatty acid production: Optimization using response surface methodology.

Su CH, Nguyen HC, Nguyen ML, Tran PT, Wang FM, Guan YL.

Biotechnol Prog. 2018 Sep;34(5):1129-1136. doi: 10.1002/btpr.2714. Epub 2018 Oct 3.

PMID:
30281955
4.

Is Androgen Deprivation Therapy "Another Deficient Therapy" for Gleason Score 9-10 Prostate Cancer?

Deek MP, Phillips RM, Haffner M, Tran PT.

Eur Urol. 2018 Sep 26. pii: S0302-2838(18)30715-2. doi: 10.1016/j.eururo.2018.09.027. [Epub ahead of print] No abstract available.

PMID:
30268657
5.

The influence of individualistic and collectivistic morality on dementia care choices.

Hanssen I, Tran PTM.

Nurs Ethics. 2018 Sep 10:969733018791342. doi: 10.1177/0969733018791342. [Epub ahead of print]

PMID:
30200811
6.

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

Moyer CL, Phillips R, Deek MP, Radwan N, Ross AE, Antonarakis ES, Reyes D, Wright J, Terezakis SA, Song DY, DeVille C, Walsh PC, DeWeese TL, Carducci M, Schaeffer EM, Pienta KJ, Eisenberger M, Tran PT.

World J Urol. 2018 Sep 6. doi: 10.1007/s00345-018-2477-2. [Epub ahead of print]

PMID:
30191396
7.

Pain and sleep quality in children with non-vascular Ehlers-Danlos syndromes.

Muriello M, Clemens JL, Mu W, Tran PT, Rowe PC, Smith CH, Francomano C, Bodurtha J, Kline AD.

Am J Med Genet A. 2018 Sep;176(9):1858-1864. doi: 10.1002/ajmg.a.40371. Epub 2018 Sep 4.

PMID:
30178919
8.

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.

Yochum ZA, Cades J, Wang H, Chatterjee S, Simons BW, O'Brien JP, Khetarpal SK, Lemtiri-Chlieh G, Myers KV, Huang EH, Rudin CM, Tran PT, Burns TF.

Oncogene. 2018 Aug 31. doi: 10.1038/s41388-018-0482-y. [Epub ahead of print]

PMID:
30171258
9.

O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.

Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya MA, Wang X, Simons BW, Ballew M, Nugent K, Groves J, Williams RD, Shiraishi T, Verdone J, Yildirir G, Henry R, Zhang B, Wong J, Wang KK, Nelkin BD, Pienta KJ, Felsher D, Zachara NE, Tran PT.

J Clin Invest. 2018 Nov 1;128(11):4924-4937. doi: 10.1172/JCI94844. Epub 2018 Sep 24.

10.

N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity.

Huan LC, Truc LC, Phuong CV, Hai PT, Huong LT, Linh NTP, Thuan NT, Park EJ, Choi YJ, Kang JS, Han SB, Nam NH, Tran PT.

Chem Biodivers. 2018 Oct;15(10):e1800322. doi: 10.1002/cbdv.201800322. Epub 2018 Sep 24.

PMID:
30054973
11.

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.

Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.

PMID:
29976500
12.

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation.

Vendetti FP, Karukonda P, Clump DA, Teo T, Lalonde R, Nugent K, Ballew M, Kiesel BF, Beumer JH, Sarkar SN, Conrads TP, O'Connor MJ, Ferris RL, Tran PT, Delgoffe GM, Bakkenist CJ.

J Clin Invest. 2018 Aug 31;128(9):3926-3940. doi: 10.1172/JCI96519. Epub 2018 Aug 13.

13.

Data integrity systems for organ contours in radiation therapy planning.

Shah VP, Lakshminarayanan P, Moore J, Tran PT, Quon H, Deville C, McNutt TR.

J Appl Clin Med Phys. 2018 Jul;19(4):58-67. doi: 10.1002/acm2.12353. Epub 2018 Jun 12.

14.

Energy Harvesting over Rician Fading Channel: A Performance Analysis for Half-Duplex Bidirectional Sensor Networks under Hardware Impairments.

Nguyen TN, Quang Minh TH, Tran PT, Vozňák M.

Sensors (Basel). 2018 Jun 1;18(6). pii: E1781. doi: 10.3390/s18061781.

15.

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.

Tran PT, Hayman J, Phillips RM.

J Clin Oncol. 2018 Aug 1;36(22):2352-2353. doi: 10.1200/JCO.2018.78.2151. Epub 2018 Jun 1. No abstract available.

PMID:
29856697
16.

Association between statin drug use and peripheral blood leukocyte telomere length in the National Health and Nutrition Examination Survey 1999-2002: a cross-sectional study.

Tran PT, Meeker AK, Platz EA.

Ann Epidemiol. 2018 Aug;28(8):529-534. doi: 10.1016/j.annepidem.2018.04.010. Epub 2018 May 14.

PMID:
29853162
17.

Synthesis, molecular modeling and biological evaluation of potent analogs of 2-methoxyestradiol.

Al-Kazaale N, Tran PT, Haidari F, Solum EJ, Liekens S, Vervaeke P, Sylte I, Cheng JJ, Vik A, Hansen TV.

Steroids. 2018 Aug;136:47-55. doi: 10.1016/j.steroids.2018.05.002. Epub 2018 May 18.

PMID:
29772242
18.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM.

Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Review.

PMID:
29726389
19.

Live to SABR Another Day?

Tran PT, Feng F, Ost P.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1097. doi: 10.1016/j.ijrobp.2018.01.104. No abstract available.

PMID:
29722652
20.

Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors.

Ngo VTH, Hoang VH, Tran PT, Van Manh N, Ann J, Kim E, Cui M, Choi S, Lee J, Kim H, Ha HJ, Choi K, Kim YH, Lee J.

Bioorg Med Chem. 2018 Jul 23;26(12):3133-3144. doi: 10.1016/j.bmc.2018.04.040. Epub 2018 Apr 19.

PMID:
29705377
21.

Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss.

Tran PT, Park DH, Kim O, Kwon SH, Min BS, Lee JH.

Int J Mol Med. 2018 Jul;42(1):569-578. doi: 10.3892/ijmm.2018.3627. Epub 2018 Apr 17.

PMID:
29693149
22.

Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit.

Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW.

BJU Int. 2018 Apr 7. doi: 10.1111/bju.14241. [Epub ahead of print]

PMID:
29626845
23.

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer.

Benzon B, Glavaris SA, Simons BW, Hughes RM, Ghabili K, Mullane P, Miller R, Nugent K, Shinder B, Tosoian J, Fuchs EJ, Tran PT, Hurley PJ, Vuica-Ross M, Schaeffer EM, Drake CG, Ross AE.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):126-136. doi: 10.1038/s41391-018-0035-z. Epub 2018 Mar 20.

PMID:
29556048
24.

Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.

Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE, Robertson SP, He P, Trieu J, Ram AN, McNutt TR, Griffith E, DeWeese TA, Honig S, Singh H, Greco SC, Tran PT, Deville C, DeWeese TL, Song DY.

Urol Oncol. 2018 Jun;36(6):309.e7-309.e14. doi: 10.1016/j.urolonc.2018.02.008. Epub 2018 Mar 16.

PMID:
29551548
25.

Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality.

Hayman J, Phillips R, Chen D, Perin J, Narang AK, Trieu J, Radwan N, Greco S, Deville C Jr, McNutt T, Song DY, DeWeese TL, Tran PT.

Prostate. 2018 Jun;78(8):623-630. doi: 10.1002/pros.23507. Epub 2018 Mar 9.

PMID:
29520847
26.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR.

JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.

27.

Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region.

Ngo VTH, Hoang VH, Tran PT, Ann J, Cui M, Park G, Choi S, Lee J, Kim H, Ha HJ, Choi K, Kim YH, Lee J.

Bioorg Med Chem. 2018 Mar 1;26(5):1035-1049. doi: 10.1016/j.bmc.2018.01.015. Epub 2018 Jan 31.

PMID:
29398442
28.

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.

Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM.

J Immunother Cancer. 2018 Jan 29;6(1):6. doi: 10.1186/s40425-018-0317-y.

29.

A prenylated flavonoid, 10-oxomornigrol F, exhibits anti-inflammatory effects by activating the Nrf2/heme oxygenase-1 pathway in macrophage cells.

Tran PL, Tran PT, Tran HNK, Lee S, Kim O, Min BS, Lee JH.

Int Immunopharmacol. 2018 Feb;55:165-173. doi: 10.1016/j.intimp.2017.12.015. Epub 2017 Dec 22.

PMID:
29258000
30.

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.

Barbhuiya MA, Mirando AC, Simons BW, Lemtiri-Chlieh G, Green JJ, Popel AS, Pandey NB, Tran PT.

Oncotarget. 2017 Sep 21;8(60):101520-101534. doi: 10.18632/oncotarget.21148. eCollection 2017 Nov 24.

31.

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer.

Phillips RM, Hayman J, Tran PT.

J Clin Oncol. 2018 Feb 10;36(5):435-437. doi: 10.1200/JCO.2017.76.5495. Epub 2017 Dec 14. No abstract available.

PMID:
29240543
32.

Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CT.

Phillips RM, Gorin MA, Rowe SP, Pomper MG, Pienta KJ, Ross AE, Tran PT.

Urol Case Rep. 2017 Nov 22;16:86-88. doi: 10.1016/j.eucr.2017.11.021. eCollection 2018 Jan. No abstract available.

33.

Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.

Topper MJ, Vaz M, Chiappinelli KB, DeStefano Shields CE, Niknafs N, Yen RC, Wenzel A, Hicks J, Ballew M, Stone M, Tran PT, Zahnow CA, Hellmann MD, Anagnostou V, Strissel PL, Strick R, Velculescu VE, Baylin SB.

Cell. 2017 Nov 30;171(6):1284-1300.e21. doi: 10.1016/j.cell.2017.10.022.

34.

Two-Year Follow-up Survey: Views of US Anesthesiologists About Health Care Costs and Future Practice Roles.

Raphael DR, Tran PT, Kain ZN, Rinehart JB.

Anesth Analg. 2018 Feb;126(2):611-614. doi: 10.1213/ANE.0000000000002571.

PMID:
29189273
35.

The Future of Radiobiology.

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ.

J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231.

36.

Anti-inflammatory activity of caffeic acid derivatives isolated from the roots of Salvia miltiorrhiza Bunge.

Choi HG, Tran PT, Lee JH, Min BS, Kim JA.

Arch Pharm Res. 2018 Jan;41(1):64-70. doi: 10.1007/s12272-017-0983-1. Epub 2017 Nov 9.

PMID:
29124660
37.

Isolation and validation of a candidate Rsv3 gene from a soybean genotype that confers strain-specific resistance to soybean mosaic virus.

Tran PT, Widyasari K, Seo JK, Kim KH.

Virology. 2018 Jan 1;513:153-159. doi: 10.1016/j.virol.2017.10.014. Epub 2017 Nov 5.

PMID:
29080441
38.

What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?

Phillips R, Ost P, Tran PT.

Future Oncol. 2017 Oct;13(24):2121-2124. doi: 10.2217/fon-2017-0337. Epub 2017 Oct 11. No abstract available.

39.

Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.

Choo YY, Tran PT, Min BS, Kim O, Nguyen HD, Kwon SH, Lee JH.

Int Immunopharmacol. 2017 Nov;52:230-237. doi: 10.1016/j.intimp.2017.09.018. Epub 2017 Sep 23.

PMID:
28946117
40.

Lis1 Has Two Opposing Modes of Regulating Cytoplasmic Dynein.

DeSantis ME, Cianfrocco MA, Htet ZM, Tran PT, Reck-Peterson SL, Leschziner AE.

Cell. 2017 Sep 7;170(6):1197-1208.e12. doi: 10.1016/j.cell.2017.08.037.

41.

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.

Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, Sinha D, Le A, Abrahams R, Tran PT, van Diest PJ, Raman V.

Oncogene. 2018 Jan 4;37(1):63-74. doi: 10.1038/onc.2017.308. Epub 2017 Sep 4.

42.

Pelvic Radiation and Normal Tissue Toxicity.

Nicholas S, Chen L, Choflet A, Fader A, Guss Z, Hazell S, Song DY, Tran PT, Viswanathan AN.

Semin Radiat Oncol. 2017 Oct;27(4):358-369. doi: 10.1016/j.semradonc.2017.04.010. Review.

PMID:
28865519
43.

A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.

Yochum ZA, Cades J, Mazzacurati L, Neumann NM, Khetarpal SK, Chatterjee S, Wang H, Attar MA, Huang EH, Chatley SN, Nugent K, Somasundaram A, Engh JA, Ewald AJ, Cho YJ, Rudin CM, Tran PT, Burns TF.

Mol Cancer Res. 2017 Dec;15(12):1764-1776. doi: 10.1158/1541-7786.MCR-17-0298. Epub 2017 Aug 29.

44.

High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.

Kates M, Chappidi MR, Brant A, Milbar N, Sopko NA, Meyer C, Terezakis SA, Herman JM, Efron JE, Safar B, Tran PT, Ahuja N, Pierorazio PM, Bivalacqua TJ.

Bladder Cancer. 2017 Jul 27;3(3):191-199. doi: 10.3233/BLC-170104.

45.

Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer.

De Bleser E, Tran PT, Ost P.

Curr Opin Urol. 2017 Nov;27(6):587-595. doi: 10.1097/MOU.0000000000000441. Review.

PMID:
28816714
46.

Engineering an auto-activated R protein that is in vivo activated by a viral protease.

Tran PT, Widyasari K, Park JY, Kim KH.

Virology. 2017 Oct;510:242-247. doi: 10.1016/j.virol.2017.07.020. Epub 2017 Jul 25.

47.

The human cytoplasmic dynein interactome reveals novel activators of motility.

Redwine WB, DeSantis ME, Hollyer I, Htet ZM, Tran PT, Swanson SK, Florens L, Washburn MP, Reck-Peterson SL.

Elife. 2017 Jul 18;6. pii: e28257. doi: 10.7554/eLife.28257.

48.

A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.

Spratt DE, Dess RT, Zumsteg ZS, Lin DW, Tran PT, Morgan TM, Antonarakis ES, Nguyen PL, Ryan CJ, Sandler HM, Cooperberg MR, Posadas E, Feng FY.

Eur Urol. 2018 Feb;73(2):156-165. doi: 10.1016/j.eururo.2017.06.027. Epub 2017 Jul 14. Review.

PMID:
28716370
49.

α-Glucosidase Inhibitory Xanthones from the Roots of Garcinia fusca.

Nguyen NK, Truong XA, Bui TQ, Bui DN, Nguyen HX, Tran PT, Nguyen LD.

Chem Biodivers. 2017 Oct;14(10). doi: 10.1002/cbdv.201700232. Epub 2017 Sep 27.

PMID:
28665538
50.

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, Pomper MG, DeWeese TL, Dicker A, Eisenberger M, Tran PT.

BMC Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.

Supplemental Content

Support Center